Re-evaluation of toxicity and long-term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial.
Grootenboers
Marco J J H
MJ
Schramel
Franz M N H
FM
van Boven
Wim J
WJ
van Putte
Bart P
BP
Hendriks
Jeroen M H
JM
Van Schil
Paul E Y
PE
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects*; D010478:Chemotherapy, Cancer, Regional Perfusion; D006801:Humans; D006979:Hyperthermia, Induced; D008137:Longitudinal Studies; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects*; D011300:Preoperative Care
D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan